MENU
AUTL
AS OF
Dec 24 closing price
Price
$1.68
Change
+$0.04 (+2.44%)
Capitalization
447.12M
75 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
AUTL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Autolus Therapeutics (AUTL) Ownership - Who owns Autolus Therapeutics?

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
191 Wood Lane
Phone
+44 2038296230
Employees
471
Web
https://www.autolus.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
447.12M
P/E Ratio
N/A
Total Cash
367.41M
Projected Growth
N/A
Total Debt
65.84M
Revenue
51.13M
Risk (Beta)
3.26
Dividend Yield
N/A
Total Cash/Share
1.38
Total Debt/Equity
N/A
Revenue/Share
0.19 USD as % of share price

Fundamentals

AUTL
Capitalization
447M
P/E Ratio
N/A
Risk (Beta)
3.26
Dividend Yield
N/A
Total Cash
367M
Total Cash/Share
1.38
Total Debt
65.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.19%
Revenue
51.1M
ROE
N/A
Book Value
265M
P/B Ratio
1.68
Cash Flow
N/A
Earnings
-0.83
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
6.19
Current Revenue Per Employee
32757.34
Dividends Per Share - Security
N/A
EBITDA
-228.64M
Float
N/A
Float - Current
N/A
Gross Income Margin
-35.15
Revenue To Assets
-30.19
Shares Held By Institutions
263M
Shares Outstanding - Current
266M
Total Liabilities
396M
Total Volume MTD
N/A
Value
1
Gain YTD
-28.511
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
AUTL
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. AUTL showed earnings on November 12, 2025. You can read more about the earnings report here.
View AI-Driven Trading for AUTL
A.I. Advisor
published General Information

General Information

a developer of cancer treatments

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
191 Wood Lane
Phone
+44 2038296230
Employees
471
Web
https://www.autolus.com